We further studied the effect of atorvastatin on the expression of MMP9, MMP12, CD36, and FABP4 in A549 cells in order to explore the possible underlying mechanism of atorvastatin inhibiting the migration of NSCLC. Here, MMP12 is linked to non-small cell lung carcinoma.